Prediction for Bronchopulmonary Dysplasia

NCT ID: NCT05181319

Last Updated: 2022-01-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

5000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-01-01

Study Completion Date

2022-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this Multi-center study performed from January 2018, we reviewed data on infants whose gestational ages were below 36 weeks. we collected data containing maternal diseases and neonatal clinical features. LASSO regression was used to select variables for the risk model. Then, we used multivariable logistic regression to build the prediction model incorporating these selected features. Discrimination was assessed by the C-index, and and calibration of the model was assessed by and calibration curve and the Hosmer-Lemeshow test.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bronchopulmonary Dysplasia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

bronchopulmonary dysplasia group

infants diagnosed with bronchopulmonary dysplasia

occurrence of bronchopulmonary dysplasia

Intervention Type OTHER

We observe the incidence of bronchopulmonary dysplasia

no bronchopulmonary dysplasia

infants not diagnosed with bronchopulmonary dysplasia

occurrence of bronchopulmonary dysplasia

Intervention Type OTHER

We observe the incidence of bronchopulmonary dysplasia

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

occurrence of bronchopulmonary dysplasia

We observe the incidence of bronchopulmonary dysplasia

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients were recruited from Multi-center Collaborative Group Hospital Neonatal Intensive Care Unit (NICU) Department.
* Patients with gestational age \<36 weeks
* admitted to the NICU within 24 h after birth
* the length of stay was more than 1 week

Exclusion Criteria

* patients with inherited disease, metabolic disorders and multiple malformations.
Maximum Eligible Age

1 Day

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kai Mu

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kai Mu

professor

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

MU Kai, Doctor

Role: STUDY_DIRECTOR

Qianfoshan Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Qianfoshan Hospital

Jinan, Shandong, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

MU Kai, Doctor

Role: CONTACT

15634883957

ZHANG Jing

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

MU Kai

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

QFS-2018-1201

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Stem Cells for Bronchopulmonary Dysplasia
NCT03378063 WITHDRAWN EARLY_PHASE1
The Baby Lung Study
NCT05152316 COMPLETED